BNTX financials
BioNTech (BNTX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BNTX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.76B | $2.14B | -$623.87M | -$1.09B | -4.51 |
| 2024 | $2.75B | $2.21B | -$1.31B | -$665.30M | -2.77 |
| 2023 | $3.82B | $3.22B | $690.40M | $930.30M | 3.83 |
| 2022 | $17.31B | $14.32B | $12.64B | $9.43B | 37.09 |
| 2021 | $18.98B | $16.07B | $15.28B | $10.29B | 41.21 |
| 2020 | $482.30M | $423.00M | -$82.40M | $15.20M | 0.06 |
- BNTX revenue was $2.76B in fiscal 2025, net income -$1.09B.
Updated 2026-11-03 02:49 UTC